Table 1

Baseline characteristics of study participants

Combination therapy n = 123Insulin therapy n = 108P value
Age (years)52 ± 152 ± 1NS
Male sex (%)4037NS
BMI (kg/m2)31.1 ± 0.530.5 ± 0.5NS
Diabetes duration (years)10.5 ± 0.510.9 ± 0.5NS
HbA1c (%)10.0 ± 0.6 10.0 ± 0.5 NS
HbA1c (mmol/mol)86 ± 5.286 ± 4.8
FPG (mg/dL)231 ± 8237 ± 7NS
Ethnicity (%)
 Qataris4839NS
 Non-Qatari Arabs2629NS
 Asian Indians1725NS
 Others97NS
Background therapy
 Metformin, mg (% of patients)1,908 (100)1,953 (100)NS
 Gliclazide, mg (% of patients)101 (58)106 (55)NS
 Glimepiride, mg (% of patients)7.4 (42)7.2 (45)NS
  • NS, not significant.